A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors Meeting Abstract
| Authors: | Lopez, J. S.; Camidge, R.; Iafolla, M.; Rottey, S.; Schuler, M.; Hellmann, M.; Balmanoukian, A.; Dirix, L.; Gordon, M.; Sullivan, R.; Henick, B. S.; Drake, C.; Wong, K.; LoRusso, P.; Ott, P.; Fong, L.; Schiza, A.; Yachnin, J.; Ottensmeier, C.; Braiteh, F.; Bendell, J.; Leidner, R.; Fisher, G.; Jerusalem, G.; Molenaar-Kuijsten, L.; Schmidt, M.; Laurie, S. A.; Aljumaily, R.; Rittmeyer, A.; Gort, E.; Melero, I.; Mueller, L.; Sabado, R.; Twomey, P.; Huang, J.; Yadav, M.; Zhang, J.; Mueller, F.; Derhovanessian, E.; Sahin, U.; Türeci, O.; Powles, T. |
| Abstract Title: | A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors |
| Meeting Title: | 111th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2020 Apr 27-28/Jun 22-24 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-08-01 |
| Language: | English |
| ACCESSION: | WOS:000590059302192 |
| DOI: | 10.1158/1538-7445.Am2020-ct301 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT301 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos |
